Diabetes News and Research

Latest Diabetes News and Research

Geron’s request for declaration of interference regarding Novocell' U.S. Patent No. 7,510,876 granted

Geron Corporation today announced that the U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences, has granted Geron’s request to declare an interference between a patent application owned by Geron and U.S. Patent No. 7,510,876 (the ‘876 patent) owned by Novocell, Inc.

15 Dec 2009

Modifications to Phase II study AD201 and open label extension study AD251 for ELND005 notified

Elan Corporation, plc and Transition Therapeutics, Inc. today notified clinical investigators of modifications to the Phase II study AD201 and open label extension study AD251 for ELND005, a compound being developed for the potential treatment of Alzheimer’s disease.

15 Dec 2009

Anthem Blue Cross to receive Tri-County Commercial contract renewal award

Anthem Blue Cross announced today that the California Department of Health Care Services intends to award Anthem the Tri-County Commercial contract renewal to provide Medi-Cal benefits to residents in the Fresno, Kings and Madera Counties.

15 Dec 2009

Poor access to safe and nutritious foods can pose serious health challenges for diabetes patients

Preparing a healthy meal loaded with fresh vegetables seems like an easy thing to do. But for some people living with diabetes, having access to nutritious food can be difficult --- and may have a detrimental effect on their health and well-being, according to a new study led by Ryerson University.

15 Dec 2009

Demystifying Psychiatry: A resource for patients and families

Psychiatric disorders are underdiagnosed, poorly treated and highly stigmatized, according to psychiatrists Charles F. Zorumski, M.D., and Eugene H. Rubin, M.D., Ph.D. So these Washington University physicians have written a book to address those problems.

15 Dec 2009

Bio-Quant becomes wholly-owned subsidiary of NexMed

NexMed, Inc., a developer of products based on the NexACT® technology, today announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA. Upon closing, Bio-Quant became a wholly-owned subsidiary of NexMed.

15 Dec 2009

Researchers to receive more than $4.5 million in grants to study Sudden Infant Death Syndrome

Researchers at the Los Angeles Biomedical Research Institute (LA BioMed) expect to receive more than $4.5 million in grants from the American Recovery and Reinvestment Act (Recovery Act.), including nearly $1 million from the highly competitive Challenge Grant program for a study that seeks to reduce the number of children who die from Sudden Infant Death Syndrome, it was announced today.

15 Dec 2009

Amgen receives worldwide rights to Array’s small-molecule glucokinase activator program

Array BioPharma Inc. and Amgen Inc.(NASDAQ: AMGN) today announced that they entered into an agreement granting Amgen exclusive worldwide rights to Array’s small-molecule glucokinase activator program, including ARRY-403, currently being tested in a Phase 1 clinical trial in patients with Type 2 diabetes.

14 Dec 2009

Postmenopausal women who take antidepressants face increased risk for stroke and death

Postmenopausal women who take antidepressants face a small but statistically significant increased risk for stroke and death compared with those who do not take the drugs. The new findings are from the federally-funded, multi-institution, Women's Health Initiative Study sponsored by the National Institutes of Health, and the results are published in the December 14 online edition of Archives of Internal Medicine.

14 Dec 2009

Tea and coffee can reduce risk of type 2 diabetes

Drinking more coffee (regular or decaffeinated) or tea appears to lower the risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine, JAMA.

14 Dec 2009

ZYPREXA RELPREVV approved by FDA

The U.S. Food and Drug Administration (FDA) approved ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today.

14 Dec 2009

Scientists present new research on adipocyte regulation

The ninth Colloque Médecine et Recherche of la Fondation Ipsen devoted to Endocrinology, held in Paris on December 4, 2009, has reviewed the recent progress in understanding the regulation of fat storage in the body and the consequences of the breakdown of this regulation.

14 Dec 2009

International experts prepare check-list for identifying insulin and cancer risk

Epidemiological studies are difficult to do well, pharmacoepidemiological studies are particularly complicated and studies of insulin and cancer risk are even more difficult to do well. "Well" in the sense that any association found can be interpreted in an unambiguous manner.

14 Dec 2009

Myrrh resin may have cholesterol-lowering properties

Laboratory experiments suggest that the resin of certain trees of the Middle East, known commonly as the "myrrh" of the Christmas story, may have cholesterol-lowering properties.

14 Dec 2009

Diabetic patients exposed to insulin glargine have higher incidence of cancer, shows study

Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications.

14 Dec 2009

Eggs of marine animals is the best dietary source of Omega 3 fatty acids

The roe of hake, lumpsucker and salmon is the best dietary source of Omega 3, according to a study carried out by researchers at the University of Almer-a (UAL). The scientists analysed the eggs, or roe, of 15 marine animals, and found all of these contained high levels of these fatty acids, which are essential to the human body.

14 Dec 2009

Changes to NCQA's disease management Accreditation and Certification standards released

The National Committee for Quality Assurance (NCQA) today released changes to its disease management Accreditation and Certification requirements, adding voluntary performance reporting for five chronic conditions.

14 Dec 2009

Senator Arlen Specter proposes new amendment to current healthcare reform bill

Senator Arlen Specter (D-PA) today proposed a new amendment to the current healthcare reform bill which will preserve access to care for millions of Medicare patients seen by a medical specialist.

14 Dec 2009

Results from Phase 2 trial evaluating Nexavar with capecitabine and paclitaxel presented

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced results from two collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trials were presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS).

14 Dec 2009

Case Western Reserve University grants option to startup Thermalin Diabetes

Case Western Reserve University has granted an 18-month, exclusive option to startup Thermalin Diabetes Inc. regarding a portfolio of insulin analogs. The company must reach certain milestones in order to exercise its option to obtain an exclusive license on therapies designed to help patients with diabetes.

14 Dec 2009

Diabetes News and Research

Latest Diabetes News and Research

Geron’s request for declaration of interference regarding Novocell' U.S. Patent No. 7,510,876 granted

Modifications to Phase II study AD201 and open label extension study AD251 for ELND005 notified

Anthem Blue Cross to receive Tri-County Commercial contract renewal award

Poor access to safe and nutritious foods can pose serious health challenges for diabetes patients

Demystifying Psychiatry: A resource for patients and families

Bio-Quant becomes wholly-owned subsidiary of NexMed

Researchers to receive more than $4.5 million in grants to study Sudden Infant Death Syndrome

Amgen receives worldwide rights to Array’s small-molecule glucokinase activator program

Postmenopausal women who take antidepressants face increased risk for stroke and death

Tea and coffee can reduce risk of type 2 diabetes

ZYPREXA RELPREVV approved by FDA

Scientists present new research on adipocyte regulation

International experts prepare check-list for identifying insulin and cancer risk

Myrrh resin may have cholesterol-lowering properties

Diabetic patients exposed to insulin glargine have higher incidence of cancer, shows study

Eggs of marine animals is the best dietary source of Omega 3 fatty acids

Changes to NCQA's disease management Accreditation and Certification standards released

Senator Arlen Specter proposes new amendment to current healthcare reform bill

Results from Phase 2 trial evaluating Nexavar with capecitabine and paclitaxel presented

Case Western Reserve University grants option to startup Thermalin Diabetes

Innovation in neuroscience drug discovery - eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Diabetes News and Research

Latest Diabetes News and Research

Innovation in neuroscience drug discovery - eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in